G8S-23727-04004 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-06-23
Registered in v-safe
2022-06-23
Dose 1 — Moderna
2022-06-24
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · Sleepiness, Irritability/crying

Under 3 check-in
2022-06-25
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-06-26
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-06-27
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-06-28
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-06-29
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-06-30
Health check-in — day 7, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-07-07
Health check-in — day 14, dose 1, under 3
Feeling: Good

Under 3 check-in
2022-07-14
Health check-in — day 21, dose 1, under 3
Feeling: Good

Under 3 check-in
2022-07-21
Health check-in — day 28, dose 1, under 3
Feeling: Good

Under 3 check-in
2022-07-28
Health check-in — day 35, dose 1, under 3
Feeling: Good

Under 3 check-in
2022-08-04
Health check-in — day 42, dose 1, under 3
Feeling: Good

Under 3 check-in
2022-09-22
Survey response — 3 months, dose 1, under 3
MedDRA: Hand-foot-and-mouth disease, Respiratory syncytial virus infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: RSV Hand foot and mouth disease

MedDRA releases: 2024-11 · check-in free text available
2022-09-22
Report sent to call center — 3 months, dose 1, under 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-09-23
Call 1 — Left Voicemail
2022-12-22
Health check-in — 6 months, dose 1, under 3
Feeling: Good

Under 3 check-in
2023-06-25
Survey response — 12 months, dose 1, under 3
MedDRA: Nasopharyngitis — Feeling: Good · Be unable to work or attend school

MedDRA releases: 2024-11

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-06-23	Moderna	No

Call center

Reported	Outcome	VAERS-related outcome
2022-09-22	Unsuccessful

Free text

Release 12 (Under 3) — 3 months, dose 1, under 3

2022-09-22

Symptoms: RSV Hand foot and mouth disease

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Hand-foot-and-mouth disease	·	·	✓
SD	Nasopharyngitis	·	·	✓
SD	Respiratory syncytial virus infection	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release